Copyright Reports & Markets. All rights reserved.

Global Quadrivalent Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Quadrivalent Flu Vaccine
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Quadrivalent Flu Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Intramuscular Injection
    • 1.3.3 Nasal Spray
    • 1.3.4 Intradermal Shot
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Quadrivalent Flu Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Public Health Agency
    • 1.4.5 Other
  • 1.5 Global Quadrivalent Flu Vaccine Market Size & Forecast
    • 1.5.1 Global Quadrivalent Flu Vaccine Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Quadrivalent Flu Vaccine Sales Quantity (2019-2030)
    • 1.5.3 Global Quadrivalent Flu Vaccine Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Sanofi Pasteur
    • 2.1.1 Sanofi Pasteur Details
    • 2.1.2 Sanofi Pasteur Major Business
    • 2.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Product and Services
    • 2.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Sanofi Pasteur Recent Developments/Updates
  • 2.2 AstraZeneca
    • 2.2.1 AstraZeneca Details
    • 2.2.2 AstraZeneca Major Business
    • 2.2.3 AstraZeneca Quadrivalent Flu Vaccine Product and Services
    • 2.2.4 AstraZeneca Quadrivalent Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 AstraZeneca Recent Developments/Updates
  • 2.3 CSL
    • 2.3.1 CSL Details
    • 2.3.2 CSL Major Business
    • 2.3.3 CSL Quadrivalent Flu Vaccine Product and Services
    • 2.3.4 CSL Quadrivalent Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 CSL Recent Developments/Updates
  • 2.4 Abbott
    • 2.4.1 Abbott Details
    • 2.4.2 Abbott Major Business
    • 2.4.3 Abbott Quadrivalent Flu Vaccine Product and Services
    • 2.4.4 Abbott Quadrivalent Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Abbott Recent Developments/Updates
  • 2.5 GlaxoSmithKline
    • 2.5.1 GlaxoSmithKline Details
    • 2.5.2 GlaxoSmithKline Major Business
    • 2.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Product and Services
    • 2.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 GlaxoSmithKline Recent Developments/Updates

3 Competitive Environment: Quadrivalent Flu Vaccine by Manufacturer

  • 3.1 Global Quadrivalent Flu Vaccine Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Quadrivalent Flu Vaccine Revenue by Manufacturer (2019-2024)
  • 3.3 Global Quadrivalent Flu Vaccine Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Quadrivalent Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Quadrivalent Flu Vaccine Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Quadrivalent Flu Vaccine Manufacturer Market Share in 2023
  • 3.5 Quadrivalent Flu Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Quadrivalent Flu Vaccine Market: Region Footprint
    • 3.5.2 Quadrivalent Flu Vaccine Market: Company Product Type Footprint
    • 3.5.3 Quadrivalent Flu Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Quadrivalent Flu Vaccine Market Size by Region
    • 4.1.1 Global Quadrivalent Flu Vaccine Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Quadrivalent Flu Vaccine Consumption Value by Region (2019-2030)
    • 4.1.3 Global Quadrivalent Flu Vaccine Average Price by Region (2019-2030)
  • 4.2 North America Quadrivalent Flu Vaccine Consumption Value (2019-2030)
  • 4.3 Europe Quadrivalent Flu Vaccine Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Quadrivalent Flu Vaccine Consumption Value (2019-2030)
  • 4.5 South America Quadrivalent Flu Vaccine Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Quadrivalent Flu Vaccine Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
  • 5.2 Global Quadrivalent Flu Vaccine Consumption Value by Type (2019-2030)
  • 5.3 Global Quadrivalent Flu Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
  • 6.2 Global Quadrivalent Flu Vaccine Consumption Value by Application (2019-2030)
  • 6.3 Global Quadrivalent Flu Vaccine Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
  • 7.2 North America Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
  • 7.3 North America Quadrivalent Flu Vaccine Market Size by Country
    • 7.3.1 North America Quadrivalent Flu Vaccine Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Quadrivalent Flu Vaccine Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
  • 8.2 Europe Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
  • 8.3 Europe Quadrivalent Flu Vaccine Market Size by Country
    • 8.3.1 Europe Quadrivalent Flu Vaccine Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Quadrivalent Flu Vaccine Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Quadrivalent Flu Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Quadrivalent Flu Vaccine Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Quadrivalent Flu Vaccine Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
  • 10.2 South America Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
  • 10.3 South America Quadrivalent Flu Vaccine Market Size by Country
    • 10.3.1 South America Quadrivalent Flu Vaccine Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Quadrivalent Flu Vaccine Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Quadrivalent Flu Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Quadrivalent Flu Vaccine Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Quadrivalent Flu Vaccine Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Quadrivalent Flu Vaccine Market Drivers
  • 12.2 Quadrivalent Flu Vaccine Market Restraints
  • 12.3 Quadrivalent Flu Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Quadrivalent Flu Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Quadrivalent Flu Vaccine
  • 13.3 Quadrivalent Flu Vaccine Production Process
  • 13.4 Quadrivalent Flu Vaccine Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Quadrivalent Flu Vaccine Typical Distributors
  • 14.3 Quadrivalent Flu Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Quadrivalent Flu Vaccine market size was valued at USD 5437.8 million in 2023 and is forecast to a readjusted size of USD 7836.6 million by 2030 with a CAGR of 5.4% during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    The Global Info Research report includes an overview of the development of the Quadrivalent Flu Vaccine industry chain, the market status of Hospital (Intramuscular Injection, Nasal Spray), Clinic (Intramuscular Injection, Nasal Spray), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Quadrivalent Flu Vaccine.
    Regionally, the report analyzes the Quadrivalent Flu Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Quadrivalent Flu Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Quadrivalent Flu Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Quadrivalent Flu Vaccine industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Doses), revenue generated, and market share of different by Type (e.g., Intramuscular Injection, Nasal Spray).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Quadrivalent Flu Vaccine market.
    Regional Analysis: The report involves examining the Quadrivalent Flu Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Quadrivalent Flu Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Quadrivalent Flu Vaccine:
    Company Analysis: Report covers individual Quadrivalent Flu Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Quadrivalent Flu Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
    Technology Analysis: Report covers specific technologies relevant to Quadrivalent Flu Vaccine. It assesses the current state, advancements, and potential future developments in Quadrivalent Flu Vaccine areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Quadrivalent Flu Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Quadrivalent Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Intramuscular Injection
    Nasal Spray
    Intradermal Shot
    Market segment by Application
    Hospital
    Clinic
    Public Health Agency
    Other
    Major players covered
    Sanofi Pasteur
    AstraZeneca
    CSL
    Abbott
    GlaxoSmithKline
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Quadrivalent Flu Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Quadrivalent Flu Vaccine, with price, sales, revenue and global market share of Quadrivalent Flu Vaccine from 2019 to 2024.
    Chapter 3, the Quadrivalent Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Quadrivalent Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Quadrivalent Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Quadrivalent Flu Vaccine.
    Chapter 14 and 15, to describe Quadrivalent Flu Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now